Literature DB >> 28424154

Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study.

Carlos A Celis-Morales1, Donald M Lyall2, Paul Welsh1, Jana Anderson2, Lewis Steell1, Yibing Guo1, Reno Maldonado1, Daniel F Mackay2, Jill P Pell2, Naveed Sattar1, Jason M R Gill3.   

Abstract

Objective To investigate the association between active commuting and incident cardiovascular disease (CVD), cancer, and all cause mortality.Design Prospective population based study. Setting UK Biobank.Participants 263 450 participants (106 674 (52%) women; mean age 52.6), recruited from 22 sites across the UK. The exposure variable was the mode of transport used (walking, cycling, mixed mode v non-active (car or public transport)) to commute to and from work on a typical day.Main outcome measures Incident (fatal and non-fatal) CVD and cancer, and deaths from CVD, cancer, or any causes.Results 2430 participants died (496 were related to CVD and 1126 to cancer) over a median of 5.0 years (interquartile range 4.3-5.5) follow-up. There were 3748 cancer and 1110 CVD events. In maximally adjusted models, commuting by cycle and by mixed mode including cycling were associated with lower risk of all cause mortality (cycling hazard ratio 0.59, 95% confidence interval 0.42 to 0.83, P=0.002; mixed mode cycling 0.76, 0.58 to 1.00, P<0.05), cancer incidence (cycling 0.55, 0.44 to 0.69, P<0.001; mixed mode cycling 0.64, 0.45 to 0.91, P=0.01), and cancer mortality (cycling 0.60, 0.40 to 0.90, P=0.01; mixed mode cycling 0.68, 0.57 to 0.81, P<0.001). Commuting by cycling and walking were associated with a lower risk of CVD incidence (cycling 0.54, 0.33 to 0.88, P=0.01; walking 0.73, 0.54 to 0.99, P=0.04) and CVD mortality (cycling 0.48, 0.25 to 0.92, P=0.03; walking 0.64, 0.45 to 0.91, P=0.01). No statistically significant associations were observed for walking commuting and all cause mortality or cancer outcomes. Mixed mode commuting including walking was not noticeably associated with any of the measured outcomes.Conclusions Cycle commuting was associated with a lower risk of CVD, cancer, and all cause mortality. Walking commuting was associated with a lower risk of CVD independent of major measured confounding factors. Initiatives to encourage and support active commuting could reduce risk of death and the burden of important chronic conditions. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Year:  2017        PMID: 28424154     DOI: 10.1136/bmj.j1456

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  90 in total

1.  Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study.

Authors:  M Abdullah Said; Niek Verweij; Pim van der Harst
Journal:  JAMA Cardiol       Date:  2018-08-01       Impact factor: 14.676

2.  The health effects of climate change: Know the risks and become part of the solutions.

Authors:  C Howard; P Huston
Journal:  Can Commun Dis Rep       Date:  2019-05-02

Review 3.  Public health: Active commuting can lower your risk of CVD.

Authors:  Irene Fernández-Ruiz
Journal:  Nat Rev Cardiol       Date:  2017-05-04       Impact factor: 32.419

4.  Doctor's prescription for cycling.

Authors:  Samantha Green; Sarah Kim; Mary Gaudet; Eileen Cheung
Journal:  Can Fam Physician       Date:  2018-10       Impact factor: 3.275

5. 

Authors:  Samantha Green; Sarah Kim; Mary Gaudet; Eileen Cheung
Journal:  Can Fam Physician       Date:  2018-10       Impact factor: 3.275

6.  The Cost-Effectiveness of Bike Share Expansion to Low-Income Communities in New York City.

Authors:  Wenya Yu; Chen Chen; Boshen Jiao; Zafar Zafari; Peter Muennig
Journal:  J Urban Health       Date:  2018-12       Impact factor: 3.671

7.  Ride report: mobile app user guide.

Authors:  Anna K Porter; Michael Schwartz
Journal:  Br J Sports Med       Date:  2017-10-24       Impact factor: 13.800

Review 8.  Large-Scale Genomic Biobanks and Cardiovascular Disease.

Authors:  Aeron M Small; Christopher J O'Donnell; Scott M Damrauer
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

9.  Protective Effect on Mortality of Active Commuting to Work: A Systematic Review and Meta-analysis.

Authors:  Frédéric Dutheil; Séverine Pélangeon; Martine Duclos; Philippe Vorilhon; Martial Mermillod; Julien S Baker; Bruno Pereira; Valentin Navel
Journal:  Sports Med       Date:  2020-12       Impact factor: 11.136

10.  Active Commuting and Multiple Health Outcomes: A Systematic Review and Meta-Analysis.

Authors:  Monica Dinu; Giuditta Pagliai; Claudio Macchi; Francesco Sofi
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.